Annals of Emergency Medicine
Volume 44, Issue 1 , Pages 20-30 , July 2004

Electrical cardioversion of emergency department patients with atrial fibrillation

Received 29 October 2003 ,Revised 11 February 2004 ,Accepted 12 February 2004.

References 

  1. Michael JA, Stiell IG, Agarwal S, et al.  Cardioversion of paroxysmal atrial fibrillation in the emergency department. Ann Emerg Med. 1999;33:379–387
  2. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation. 2003;108:711–716
  3. Feinberg WM, Blackshear JL, Laupacis A, et al.  Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995;155:469–473
  4. The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation . Atrial fibrillation: current understandings and research imperatives. J Am Coll Cardiol. 1993;22:1830–1834
  5. Li H, Easley A, Barrington W, et al.  Evaluation and management of atrial fibrillation in the emergency department. Emerg Med Clin North Am. 1998;16:389–403
  6. American Heart Association . Advanced Cardiac Life Support. Dallas, TX: American Heart Association; 1997; 1-33
  7. Anonymous . Proceedings of the American College of Chest Physicians 5th consensus on antithrombotic therapy. Chest. 1998;114:439S–769S
  8. Fuster V, Ryden LE, Asinger RW, et al.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol. 2001;38:1266–1334
  9. de Latorre F, Nolan J, Robertson C, et al.  European Resuscitation Council Guidelines 2000 for adult advanced life support. Resuscitation. 2001;48:211–221
  10. Koenig BO, Ross MA, Jackson RE. An emergency department observation unit protocol for acute-onset atrial fibrillation is feasible. Ann Emerg Med. 2002;39:374–381
  11. Snow V, Weiss KB, LeFevre M, et al.  Management of newly detected atrial fibrillation: a practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med. 2003;139:1009–1017
  12. Weigner MJ, Caulfield TA, Danias PG, et al.  Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med. 1997;126:615–620
  13. Gentile F, Elhendy A, Khandheria BK, et al.  Safety of electrical cardioversion in patients with atrial fibrillation. Mayo Clin Proc. 2002;77:897–904
  14. Jung F, DiMarco JP. Treatment strategies for atrial fibrillation. Am J Med. 1998;104:272–286
  15. Domanovits H, Schillinger M, Thoennissen J, et al.  Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion. Resuscitation. 2000;45:181–187
  16. Page RL, Kerber RE, Russell JK, et al.  Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol. 2002;39:1956–1963
  17. Berger M, Schweitzer P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. Am J Cardiol. 1998;82:1545–1547 A8
  18. Manning WJ, Silverman DI, Katz SE, et al.  Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. Am J Cardiol. 1995;75:624–626
  19. Grimm RA, Leung DY, Black IW, et al.  Left atrial appendage “stunning” after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography. Am Heart J. 1995;130:174–176
  20. Bellotti P, Spirito P, Lupi G, et al.  Left atrial appendage function assessed by transesophageal echocardiography before and on the day after elective cardioversion for nonvalvular atrial fibrillation. Am J Cardiol. 1998;81:1199–1202
  21. Harjai K, Mobarek S, Abi-Samra F, et al.  Mechanical dysfunction of the left atrium and the left atrial appendage following cardioversion of atrial fibrillation and its relation to total electrical energy used for cardioversion. Am J Cardiol. 1998;81:1125–1129
  22. Antonielli E, Pizzuti A, Bassignana A, et al.  Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation. Am J Cardiol. 1999;84:1092–1100
  23. Falcone RA, Morady F, Armstrong WF. Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation. Am J Cardiol. 1996;78:435–439
  24. Klein AL, Grimm RA, Murray RD, et al.  Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 2001;344:1411–1420
  25. Mead GE, Flapan AD, Elder AT. Electrical cardioversion for atrial fibrillation and flutter. Cochrane Database Sys Rev. 2002;1:CD002903
  26. Wyse DG, Waldo AL, DiMarco JP, et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–1833
  27. Fresco C, Proclemer A. Clinical challenge, (II: management of recent onset atrial fibrillation: PAFIT-2 Investigators). Eur Heart J. 1996;17(Suppl C):41–47
  28. Mulcahy B, Coates WC, Henneman PL, et al.  New-onset atrial fibrillation: when is admission medically justified. Acad Emerg Med. 1996;3:114–119
  29. Marcus GM, Sung RJ. Antiarrythmic agents in facilitating electrical cardioversion of atrial fibrillation and promoting maintenance of sinus rhythm. Cardiology. 2001;95:1–8
  30. Oral H, Souza J, Michaud GF, et al.  Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med. 1999;340:1849–1854
  31. Cotter G, Blatt A, Kaluski E, et al.  Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone: a randomized, placebo-controlled study. Eur Heart J. 1999;20:1833–1842
  32. Danias PG, Caulfield TA, Weigner MJ, et al.  Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J Am Coll Cardiol. 1998;31:588–592
  33. Dell'Orfano JT, Patel H, Wolbrette DL, et al.  Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care. Am J Cardiol. 1999;83:788–790
  34. Naccarelli GV, Dell'Orfano JT, Wolbrette DL, et al.  Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy. Am J Cardiol. 2000;85:36D–45D
  35. Wang TJ, Massaro JM, Levy D, et al.  A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community. JAMA. 2003;290:1049–1056
  36. Zarkin GA, Bala MV, Calingaert B, et al.  The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm. Am J Managed Care. 1997;3:1387–1394

 Author contributions: JHB conceived the study. JHB, DRV, TDS, and KD were participants in study design. All authors participated in and were responsible for data retrieval and record query. JHB was responsible for data management for the entire study. Abstract preparation was undertaken by JHB, DRV, KD, and TDS. HCT and JHB performed statistical review and management. JHB, HCT, and DRV were responsible for initial manuscript preparation, with all authors participating in final manuscript editing and submission for publication. JHB takes responsibility for the paper as a whole.

☆☆ Presented at the Society for Academic Emergency Medicine annual meeting, Boston, MA, May 2003.

 The authors report this study did not receive any outside funding or support.

★★ Reprints not available from the authors.

PII: S0196-0644(04)00179-9

doi: 10.1016/j.annemergmed.2004.02.016

Annals of Emergency Medicine
Volume 44, Issue 1 , Pages 20-30 , July 2004